Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine
Clinical trial NCT01442662 · COMPLETED
Trial details
- NCT number
- NCT01442662
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2018-03-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.